Skip to main content

Day: August 9, 2021

GSI Technology to Participate in AWS OpenSearch

SUNNYVALE, Calif., Aug. 09, 2021 (GLOBE NEWSWIRE) — GSI Technology, Inc. (Nasdaq: GSIT), a leading provider of high-performance memory solutions for the networking, telecommunications, and military markets, and developer of the Gemini® Associative Processing Unit (APU) for Artificial Intelligence, today announced it is partnering with Amazon Web Services (AWS) OpenSearch Community for its AWS OpenSearch 1.0 launch. “GSI is proud to participate with AWS in its OpenSearch 1.0 launch,” said Lee-Lean Shu. “GSI Technology has successfully proven that its Gemini APU significantly accelerates vector search performance in such applications as e-commerce, drug discovery, natural language processing (NLP) and visual search with the added benefit of low power. As an AWS OpenSearch Service partner, GSI can expand the APU’s market reach into...

Continue reading

Acer Therapeutics and Relief Therapeutics Announce Submission of a New Drug Application to the U.S. FDA for ACER-001 for Treatment of Urea Cycle Disorders

NEWTON, Mass. and GENEVA, Aug. 09, 2021 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq: ACER) (“Acer”), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, and RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) (“Relief”), a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for ACER-001 (sodium phenylbutyrate) for the treatment of Urea Cycle Disorders (UCDs). ACER-001 is a nitrogen-binding agent in development for use as adjunctive therapy in the chronic management of patients with UCDs involving deficiencies of carbamylphosphate...

Continue reading

Cellectar Reports Financial Results for the Second Quarter 2021 and Provides a Corporate Update

FLORHAM PARK, N.J., Aug. 09, 2021 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced financial results for the second quarter ended June 30, 2021 and provided a corporate update. Second Quarter and Recent Corporate HighlightsAnnounced the expansion of the ongoing collaboration with biotechnology company IntoCell Inc., combining their novel linker chemistry with Cellectar’s validated targeting platform to create novel next generation phospholipid drug conjugate (PDC) therapeutics.Announced a co-development and commercialization collaboration with LegoChemBio, a clinical stage biotechnology company to utilize their proprietary drug conjugate linker-toxin platform to further...

Continue reading

Earth Gen Biofuel Inc. Mid-Year Operations Update.

Salem, Oregon, Aug. 09, 2021 (GLOBE NEWSWIRE) — Earth Gen-Biofuel Inc.(OTC:EGBB) midyear update. As one of America’s premier builders of tiny homes, Earth Gen Biofuel Inc. (“EGBB”) continues to expand its production capacity. EGBB manufacturing operations are now concentrated in the International Housing Concepts Inc. (“IHC”), subsidiary in its 70,000 square foot facility in Salem Oregon. In 2021 EGBB repositioned its sales strategy by focusing on RV Park developers, tiny home retailers, and municipal decision-makers throughout the Pacific Northwest. This has resulted in valuable new relationships and the addition of multiple new clients and increased sales orders. The company has benefited from its expanded network of dealers in providing consumer feedback, resulting in new and exciting floorplans, modern exterior and interior...

Continue reading

Longboard Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2021 Financial Results

Continued progress with the multiple ascending dose (MAD) portion of the Phase 1 clinical trial for LP352, a potential treatment for severe epileptic indications, with topline results expected in 2021Initiated a number of IND-enabling preclinical studies for LP143 and LP659 Established corporate office in one of the largest life sciences hubs, San Diego, California, while continuing to expand capabilities internationally as we build out a world-class neurology teamSAN DIEGO, Aug. 09, 2021 (GLOBE NEWSWIRE) — Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today provided a corporate update and reported financial results for the second quarter ended June 30, 2021. “This quarter we were highly focused on...

Continue reading

Monmouth Comments on ISS Report

ISS Recognizes Monmouth Board Ran Organized and Thorough Strategic Alternatives Process and Acknowledges the Benefits of a Transaction with EQC Monmouth Urges Stockholders to Vote the WHITE Proxy Card “FOR” the Equity Commonwealth Transaction HOLMDEL, N.J., Aug. 09, 2021 (GLOBE NEWSWIRE) — Monmouth Real Estate Investment Corporation (NYSE: MNR, “Monmouth” or “the Company”) today commented on the recent report from independent proxy advisory firm Institutional Shareholder Services, Inc. (“ISS”) related to the Company’s pending merger with Equity Commonwealth (NYSE: EQC, “EQC”):  Following an extensive strategic review conducted by the Monmouth Board, our Board unanimously determined that merging with EQC is the best path forward for the Company. A merger with EQC uniquely positions the combined company to evolve into a market...

Continue reading

Safe-T Group to Host Second Quarter 2021 Financial Results Conference Call on Thursday, August 26, 2021 at 8:30 a.m. Eastern Time

HERZLIYA, Israel, Aug. 09, 2021 (GLOBE NEWSWIRE) —  Safe-T® Group Ltd. (NASDAQ, TASE: SFET), a global provider of cyber-security and privacy solutions to consumers and enterprises, will release its financial results for the second quarter and six-month period ended June 30, 2021, before the Nasdaq market opens on Thursday, August 26, 2021. Mr. Shachar Daniel, Chief Executive Officer, and Mr. Shai Avnit, Chief Financial Officer, will host a conference call on August 26, 2021, at 08:30 a.m. ET, to discuss the financial results, followed by a Q&A session. To attend the conference call, please dial one of the following teleconferencing numbers. Please begin by placing your call five minutes before the conference call commences. If you are unable to connect using the toll-free number, please try the international dial-in number:Date: Thursday,...

Continue reading

Overstock.com Ranked No. 2 On National Retail Federation’s 2021 Hot 25 Retailers List

SALT LAKE CITY, Aug. 09, 2021 (GLOBE NEWSWIRE) — Overstock.com, Inc. (NASDAQ:OSTK), a leading e-commerce home furnishings retailer, has received the No. 2 ranking on the National Retail Federation’s annual Hot 25 Retailers list. The list ranks the nation’s fastest-growing retail companies, as determined by increases in domestic sales between 2019 and 2020. Overstock placed No. 2 after achieving 75 percent sales growth with $2.5 billion in 2020 up from $1.5 billion in 2019. “This recognition from the National Retail Federation reflects our strategic focus on our home business and our team’s ability to deliver results during a difficult year,” said Jonathan Johnson, Overstock CEO. “Overstock has exceptional employees who work hard every day to profitably grow our market share. We are well poised for continued success for the rest...

Continue reading

US Nuclear and Partners Enter Vehicle Electrification Challenge Led by Rio Tinto and World’s Biggest Mining Companies

US Nuclear Corp.US Nuclear and PartnersLOS ANGELES, CA, Aug. 09, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – US Nuclear Corp. (OTCQB: UCLE) and partners now enter the electric vehicle fast charging and propulsion market which is expected to exceed 15 Billion per year by 2030. To do this our group has formed a consortium with Grapheton, Solar System Resources and Four Point, called ChargeMineBetter which has submitted an offer in the ‘Charge On Innovation Challenge.’ Our group’s technology uses a supercapacitor system developed using Grapheton’s novel technology. ChargeMineBetter’s organic vapor phase deposition, OVHPD technology reduces carbon footprint, solves the challenge, and will enable the industry to save billions of dollars and move towards their goal of de-carbonizing the mining industry. The Charge...

Continue reading

Ecolab Opens Healthcare Advanced Design Center to Drive Innovation for the Medical Device Industry

End-to-end design and manufacturing of custom sterile barriers for robotic and diagnostic surgical equipment will help improve patient outcomes ST. PAUL, Minn., Aug. 09, 2021 (GLOBE NEWSWIRE) — Ecolab Inc., the global leader in water, hygiene and infection prevention solutions and services, is opening the Ecolab Healthcare Advanced Design Center in Eagan, Minn. The state-of-the art, 22,000-square-foot innovation center will enable Ecolab Healthcare to partner with medical device industry customers on infection prevention solutions for their cutting-edge surgical equipment and develop new solutions for hospitals and surgery centers. Custom-designed sterile barriers and equipment drapes help hospitals and surgery centers boost infection prevention measures, improve patient outcomes and manage operational costs and efficiencies. “The...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.